Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 24,173 shares at $8.95 ($215K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Open-market sale of $215k PHAT by CFO and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.80 | 811 | $6K | 2.9% |
| 2 | $8.95 | 11,681 | $105K | 48.5% |
| 3 | $8.95 | 11,681 | $105K | 48.5% |
| Total | $8.91 avg | 24,173 | $215K | 100% |
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |